Pharma channel feed

Ac­qui­si­tion talks on­go­ing for Swedish rare dis­ease biotech Egetis, shares up al­most 40%

3 years ago
Deals

Lu­pus drug de­vel­op­ment mar­ket heat­ing up, while FDA links with ad­vo­ca­cy group to fur­ther ac­cel­er­ate re­search

3 years ago
FDA+
Marketing

Mod­er­na so­lid­i­fies deal with Kenya to build mR­NA man­u­fac­tur­ing fa­cil­i­ty

3 years ago
Deals
Manufacturing

Ther­mo Fish­er moves on cam­pus with new cell man­u­fac­tur­ing site in San Fran­cis­co

3 years ago
Manufacturing

GSK picks up Scynex­is' FDA-ap­proved an­ti­fun­gal drug for $90M up­front

3 years ago
Deals

Q&A: New­ly-mint­ed CSL chief ex­ec­u­tive Paul McKen­zie and chief med­ical of­fi­cer Bill Mez­zan­otte

3 years ago
People

Big Phar­ma-part­nered clin­i­cal tri­al match­mak­er se­cures $20M to im­prove plat­form

3 years ago
Financing

Ot­su­ka, Lund­beck eye Alzheimer's in­di­ca­tion in FDA ad­comm for Rex­ul­ti la­bel ex­pan­sion

3 years ago
FDA+

Boehringer re­ports ro­bust sales led by type 2 di­a­betes and pul­monary drugs, promis­es more to come high­light­ing obe­si­ty

3 years ago
Marketing

FDA ap­proves Nar­can opi­oid over­dose re­ver­sal spray for over-the-counter sale

3 years ago
FDA+
Marketing

J&J bows out of RSV vac­cine race, end­ing PhI­II study and ced­ing to Pfiz­er, GSK

3 years ago
R&D

As­traZeneca ax­es li­cense agree­ment with Aridis, plac­ing Eu­rope-fund­ed PhI­II on hold

3 years ago
Deals

Ohio at­tor­ney gen­er­al sues sev­er­al PBMs over an­titrust con­cerns

3 years ago
Law

Phar­ma ad to­tal tops $8B again in 2022, led by top brands from Sanofi and Re­gen­eron, Ab­b­Vie

3 years ago
Marketing

House com­mit­tee to in­ves­ti­gate FDA's re­sponse to on­go­ing drug short­ages

3 years ago
FDA+
Manufacturing

Q&A: Pfiz­er cor­po­rate com­mu­ni­ca­tions chief Sal­ly Sus­man dis­cuss­es book craft­ed in pan­dem­ic and per­son­al lessons

3 years ago
Marketing

Mar­ket­ingRx roundup: Ab­b­Vie dri­ves en­dometrio­sis aware­ness; No­var­tis adds to Cosen­tyx cam­paign

3 years ago
Marketing

Evotec’s CNS deal with Bris­tol My­ers gets $50M in­fu­sion and eight-year ex­ten­sion

3 years ago
Deals

Gun­ning for 2023 ap­proval, GSK de­tails PhI­II da­ta for Jem­per­li in front­line en­dome­tri­al can­cer

3 years ago
R&D

Es­pe­ri­on sues Dai­ichi Sankyo, de­mand­ing pay­ment of $300M mile­stone for car­dio drug

3 years ago
Law

Mer­ck KGaA takes back con­trol of PD-L1 can­cer drug as Pfiz­er al­liance ends

3 years ago
Deals

Eli Lil­ly to in­crease in­vest­ment to $1B in­to new Irish man­u­fac­tur­ing fa­cil­i­ty — re­port

3 years ago
Manufacturing

Sen­a­tor asks FTC to in­ves­ti­gate Amerisource­Ber­gen over abor­tion pill dis­tri­b­u­tion plans

3 years ago

Re­silience notch­es $410M in fed­er­al fi­nanc­ing to bol­ster pro­duc­tion

3 years ago
Financing
Manufacturing
First page Previous page 131132133134135136137 Next page Last page
A service from the Financial Times